Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.
Platz
K P
KP
Department of Surgery, Virchow Clinic, Humboldt University, Berlin, Germany.
Mueller
A R
AR
Willimski
C
C
Mansoorian
B
B
Berg
T
T
Neuhaus
R
R
Hopf
U
U
Radke
C
C
Neuhaus
P
P
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy*; D016174:Hepacivirus / Q000302:isolation & purification / Q000502:physiology; D006526:Hepatitis C / Q000175:diagnosis / Q000503:physiopathology* / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000209:etiology / Q000601:surgery*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012367:RNA, Viral / Q000097:blood; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors; D014779:Virus Replication / Q000187:drug effects
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D012367:RNA, Viral; D016572:Cyclosporine; C079843:inolimomab; D009173:Mycophenolic Acid